NCT05672420 2023-01-05
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Unknown
Clinical Trials
19 trialsNCT04632316 2022-06-21
A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
Glycostem Therapeutics BV
Phase 1/2 Unknown
NCT04082910 2022-04-13
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT05250362 2022-03-15
Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation
Sichuan University
Phase 1/2 Unknown
NCT03821519 2021-12-23
Haplo-CIK
A.O. Ospedale Papa Giovanni XXIII
Phase 1/2 Unknown
NCT04622956 2021-09-14
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
University of Sao Paulo General Hospital
Phase 1/2 Unknown
NCT05028478 2021-08-31
A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies
Curon Biopharmaceutical (Australia) Co Pty Ltd
Phase 1/2 Unknown
NCT04790747 2021-03-10
Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions
Zhejiang University
Phase 1/2 Unknown
NCT02828878 2019-11-26
Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation
Cellect Biotechnology
Phase 1/2 Unknown
NCT03185494 2019-04-17
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT02032446 2019-01-18
PTC-UC-MSC
A.O. Ospedale Papa Giovanni XXIII
Phase 1/2 Unknown
NCT03091933 2017-12-06
GLIDE
Ciusss de L'Est de l'Île de Montréal
Phase 1/2 Unknown
NCT02685670 2017-03-16
MatchCART
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine
Phase 1/2 Unknown
NCT02903810 2016-10-12
Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy
Xuzhou Medical University
Phase 1/2 Unknown
NCT01735604 2015-09-29
Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory to Chemotherapy
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT00524784 2015-06-11
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD
Hadassah Medical Organization
Phase 1/2 Unknown
NCT02081937 2014-03-11
CART-19 Immunotherapy in Mantle Cell Lymphoma
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT00930566 2013-04-24
ECP
Hospices Civils de Lyon
Phase 1/2 Unknown
NCT00580450 2007-12-24
Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies
University Of Perugia
Phase 1/2 Unknown